Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID‐19: A propensity score‐matched analysis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15517
Abstract: Coronavirus disease 2019 (COVID‐19) is associated with hypercoagulability and increased thrombotic risk. The impact of prehospital antiplatelet therapy on in‐hospital mortality is uncertain. read more here.
Keywords: prehospital antiplatelet; antiplatelet therapy; therapy survival; association prehospital ... See more keywords
Response to systemic therapy and survival outcomes in de-novo (D1) metastatic castration-sensitive prostate cancer (mCSPC) versus mCSPC with prior local therapy (D0).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.46
Abstract: 46Background: A real-world study (n= 436, PMID: 29707790) suggest that D1 mCSPC has worse outcomes than D0 mCSPC. The objective of our study is to validate these findings in a real-world setting, a... read more here.
Keywords: mcspc; therapy survival; systemic therapy; survival outcomes ... See more keywords